Literature DB >> 7028079

Bone marrow transplantation in severe aplastic anaemia: a survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.).

E Gluckman, A J Barrett, W Arcese, A Devergie, P Degoulet.   

Abstract

A survey of the results of bone marrow transplantation for severe aplastic anaemia in 13 European teams is reported. 159 questionnaires were analysed by univariate and multivariate analysis. The overall 1 year survival was 41.2%. The chance of survival was decreased by the presence of infection before grafting and by the use of female donors. The conditioning regimen did not influence survival. Graft rejection was influenced by the conditioning regimen and the sex of the donor. Graft-versus-host disease was influenced by the conditioning regimen, and the age and the sex of the recipient. This study defines prognostic indices which may be helpful in determining the likelihood of success after marrow transplantation for severe aplastic anaemia.

Entities:  

Mesh:

Year:  1981        PMID: 7028079     DOI: 10.1111/j.1365-2141.1981.tb07212.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  The haemolytic uraemic syndrome and bone marrow transplantation.

Authors:  J I Craig; T Sheehan; K Bell
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-10

2.  Recent developments in allogeneic marrow transplantation for the treatment of severe aplastic anemia.

Authors:  R Storb
Journal:  Blut       Date:  1981-12

Review 3.  Stem cell transplantation for aplastic anemia.

Authors:  George E Georges; Rainer Storb
Journal:  Int J Hematol       Date:  2002-02       Impact factor: 2.490

4.  Activity of C1 esterase inhibitor in patients with vascular leak syndrome after bone marrow transplantation.

Authors:  W Nürnberger; I Michelmann; K Petrik; S Holthausen; R Willers; G Lauermann; B Eisele; U Delvos; S Burdach; U Göbel
Journal:  Ann Hematol       Date:  1993-07       Impact factor: 3.673

Review 5.  Acute graft-versus-host disease after allogeneic bone marrow transplantation.

Authors:  C Perreault; M Gyger; J Boileau; Y Bonny; S Cousineau; M Lacombe; R Lavallee; E Tawil; G D'Angelo
Journal:  Can Med Assoc J       Date:  1983-11-01       Impact factor: 8.262

6.  High dose bolus methylprednisolone for the treatment of acute graft versus host disease.

Authors:  A Bacigalupo; M T van Lint; F Frassoni; M Podesta'; G Veneziano; G Avanzi; V Vitale; A M Marmont
Journal:  Blut       Date:  1983-03

7.  Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: preliminary results.

Authors:  M Horstmann; M Stockschläder; W Krüger; M Hoffknecht; R Betker; H Kabisch; A Zander
Journal:  Ann Hematol       Date:  1995-08       Impact factor: 3.673

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.